PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, ? PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, ? PerCP/Cyanine5.5 isotype control (open histogram).
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability
103131 25 µg $87.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103132 100 µg $221.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  2. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  3. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  4. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  5. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  6. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  7. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  8. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  9. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  10. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  11. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  12. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  13. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  14. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  15. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  16. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  17. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  18. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  19. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  20. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  21. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  22. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  23. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  24. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  25. Li X, et al. 2022. Cell. 185:1709. PubMed
  26. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  27. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  28. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  29. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  30. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  31. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  32. Zaman R, et al. 2021. Immunity. :. PubMed
  33. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  34. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  35. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  36. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  37. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  38. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  39. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  40. Shi H, et al. 2022. Nutrients. 14:. PubMed
  41. Li J, et al. 2022. Elife. 11:. PubMed
  42. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  43. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  44. He Y, et al. 2023. Biomolecules. 13:. PubMed
  45. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  46. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
  47. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  48. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  51. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  52. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  53. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  54. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  55. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  56. Li Z, et al. 2021. Immunology. 163:105. PubMed
  57. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  58. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  59. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  60. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  63. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  64. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  65. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  66. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  67. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  68. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  69. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  70. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  71. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  72. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  73. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  74. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  75. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  76. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  79. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  80. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  81. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  82. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  83. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  84. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  85. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  86. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  87. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  88. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  89. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  90. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  91. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  92. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  93. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  94. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  95. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  96. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  97. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  98. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  99. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  100. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  101. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  102. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  103. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  104. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  105. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  106. Wei SC, et al. 2020. Cancer Discov. . PubMed
  107. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  108. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  109. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  110. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  111. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  112. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  113. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  114. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  115. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  116. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  117. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  118. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  119. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  120. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  121. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  122. Li N, et al. 2021. eLife. 10:00. PubMed
  123. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  124. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  125. Christ A, et al. 2018. Cell. 172:162. PubMed
  126. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  127. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  128. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  129. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  130. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  131. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  132. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  133. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  134. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  135. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  136. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  137. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  138. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  139. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  140. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  141. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  142. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  143. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  144. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  145. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  146. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  147. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  148. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  149. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  150. Lang V, et al. 2021. Elife. 10:. PubMed
  151. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  152. Weinstock A, et al. 2021. Elife. :10. PubMed
  153. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  154. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  155. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  156. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  157. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  158. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  159. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  160. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  161. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  162. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  163. Thomas K, et al. 2022. JCI Insight. :. PubMed
  164. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  165. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  166. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  167. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  168. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  169. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  170. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  171. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  172. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  173. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  174. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  175. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  176. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  177. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  178. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  179. Calle P, et al. 2021. Cells. 10:. PubMed
  180. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  181. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  182. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  183. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  184. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  185. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  186. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  187. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  188. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  189. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  190. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  191. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  192. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  193. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  194. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  195. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  196. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  197. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  198. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  199. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  200. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  201. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  202. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  203. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  204. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  205. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  206. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  207. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  208. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  209. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  210. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  211. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  212. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  213. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  214. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  215. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  216. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  217. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  218. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  219. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  220. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  221. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  222. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  223. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  224. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  225. Liu SS, et al. 2021. Immunity. :. PubMed
  226. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  227. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  228. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  229. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  230. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  231. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  232. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  233. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  234. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  235. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  236. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  237. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  238. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  239. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  240. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  241. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  242. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  243. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  244. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  245. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  246. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  247. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  248. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  249. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 3    Revision Date: 08/24/2018

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account